Depo: the debate continues.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced; D003692:Delayed-Action Preparations; D003906:Developing Countries; D004285:Dogs; D005260:Female; D006801:Humans; D007267:Injections; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D011247:Pregnancy; D014481:United States; D014486:United States Food and Drug Administration
D003692:Delayed-Action Preparations; D008525:Medroxyprogesterone